GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (HKSE:02279) » Definitions » ROC %

Yonghe Medical Group Co (HKSE:02279) ROC % : -3.60% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Yonghe Medical Group Co's annualized return on capital (ROC %) for the quarter that ended in Dec. 2024 was -3.60%.

As of today (2025-03-31), Yonghe Medical Group Co's WACC % is 6.99%. Yonghe Medical Group Co's ROC % is -5.76% (calculated using TTM income statement data). Yonghe Medical Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Yonghe Medical Group Co ROC % Historical Data

The historical data trend for Yonghe Medical Group Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co ROC % Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC %
Get a 7-Day Free Trial 15.97 8.10 -5.73 -18.86 -5.74

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.02 -17.09 -19.96 -7.73 -3.60

Yonghe Medical Group Co ROC % Calculation

Yonghe Medical Group Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2024 is calculated as:

ROC % (A: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2023 ) + Invested Capital (A: Dec. 2024 ))/ count )
=-133.132 * ( 1 - 11.25% )/( (2445.746 + 1671.542)/ 2 )
=-118.15465/2058.644
=-5.74 %

where

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2673.809 - 133.533 - ( 659.784 - max(0, 790.694 - 885.224+659.784))
=2445.746

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1842.994 - 81.657 - ( 520.855 - max(0, 582.641 - 672.436+520.855))
=1671.542

Yonghe Medical Group Co's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-83.152 * ( 1 - 19.04% )/( (2071.037 + 1671.542)/ 2 )
=-67.3198592/1871.2895
=-3.60 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2246.528 - 108.371 - ( 574.637 - max(0, 706.988 - 774.108+574.637))
=2071.037

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1842.994 - 81.657 - ( 520.855 - max(0, 582.641 - 672.436+520.855))
=1671.542

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yonghe Medical Group Co  (HKSE:02279) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Yonghe Medical Group Co's WACC % is 6.99%. Yonghe Medical Group Co's ROC % is -5.76% (calculated using TTM income statement data). Yonghe Medical Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Yonghe Medical Group Co ROC % Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yonghe Medical Group Co Business Description

Traded in Other Exchanges
N/A
Address
11th Floor, 20 Ganluyuan Nanli, China Nuclear E&C Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. It is principally engaged in the provision of hair transplant services which are subject to similar types of services, similar classes of customers, similar regulatory environment, and similar business risk. The company generated the majority of the revenue from hair transplant services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
Executives
Zhang Yu 2307 Founder of a discretionary trust who can infl
Cyh Cosmetic Medical Investment Limited
Pan Mao Shang Hai Tou Zi Zhong Xin You Xian He Huo
Shang Hai Pan Nuo Qi Ye Guan Li Fu Wu You Xian Gong Si
Zhong Xin Chan Ye Tou Zi Ji Jin Guan Li You Xian Gong Si
Zy Ventures Ltd
Zy Investment Capital Ltd
Yonghe Hair Service Holdings Limited
Cyh Cosmetic Medical Holdings Limited
Cpechina Fund Iia, L.p.
Cpechina Fund Ii, L.p.
Citron Pe Holdings Limited
Citron Pe Funds Ii Limited
Citron Pe Associates Ii, L.p.
Citic Securities Company Limited

Yonghe Medical Group Co Headlines

No Headlines